Trial Profile
ARK Kraaifontein PMTCT trial
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2018
Price :
$35
*
At a glance
- Drugs Lamivudine/zidovudine (Primary) ; Lopinavir/ritonavir (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms ARKKFTN
- 30 Sep 2011 New trial record